InvestorsHub Logo

polscigeek

05/08/14 11:07 AM

#7032 RE: nuketheshorts #7029

These other company's are not robotic surgery companies. They're selling many other products and services, and oh by the way they're going to be selling robots too. There will be many, many competitors coming to market. But remember, this is the dawn of the robotic surgery age. It's like the start of the automobile industry. Many, many, many people wanted to start building cars, and several did. But 100 years later there are basically only a handful left standing. The life cycle of an industry is pretty much the same regardless of the product or service. To survive long term you have to be hyper focused and that's going to be hard to do when you have dozens of different products in several different markets. Titan is a robotic surgery firm. ISRG is a robotic surgery firm. They won't be selling anything that doesn't pertain to their robots and are hyper focused on R&D and making robotic surgery safer and more economical. That's the difference.

A company that sells lasers and builds a robot to operate their lasers will never be in competition with TITXF or ISRG. Anyone building robots for the peritoneum cavity (from under the rib cage to the pelvic floor) will be a direct competitor to Titan and Intuitive.

longtermgems

05/08/14 11:52 AM

#7033 RE: nuketheshorts #7029

TRXC and TITXXF are the two real robotic surgical up and coming companies looking to compete with ISRG. But TRXC is much farther ahead than TITXF and in my opinion offers a much more appealing investment. The company also is developing flexible advanced energy device (only rigid devices exist, and this market is growing rapidly) and the companies product does not produce any plume or smoke as mentioned in the CC, A HUGE ADVANTAGE!

So TRXC is now penetrating the advanced energy device market, and surgical robot market, and the company has its final design protoype set for the surgibot and its already been submitted to the FDA. TITXF is still in the developmental stages with their robot and have not finished the ultimate design (theyre still modifying it).

Also TRXC is patient side which provided true tactile feel and is the major advantage over ISRGs console system. This CC was extremely enlightening for any surgical robot investor.